Kairos Pharma Presents at United Scientific Group’s 11th International Conference on Cancer Research & Drug Development

Posted on by sHq_LoGiNz

LOS ANGELES–(BUSINESS WIRE)–Neil Bhowmick, President and CSO of Kairos Pharma, presents on lead candidate ENV-105 and its interim efficacy results at Cancer R&D 2026.

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance (opens in a new tab)
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.